CIK 0001604950
SCPH scPharmaceuticals Inc.
Insider trading from SEC Form 4. Last filing Oct 7, 2025.
scPharmaceuticals Inc. (SCPH) has 18 SEC Form 4 filings on file from 10 insiders, the latest filed on Oct 7, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
10
with a Form 4 at this company
Signals
Open-market buys and sells at scPharmaceuticals Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The newest 50 of 51 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | John H Tucker President and CEO | UTender of shares Common Stock | -122,345 | - | - | 318,502 | Oct 7, 2025 |
| Oct 7, 2025 | Jack A. Khattar director | UTender of shares Common Stock | -5,000 | - | - | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Leonard D Schaeffer director | UTender of shares Common Stock | -68,796 | - | - | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Minnie Baylor-Henry director | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | William Tober Abraham director | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Klaus R Dr Veitinger director | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Frederick M. Hudson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Sara Bonstein director | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Mette Kirstine Agger director | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Rachael Nokes CFO and Treasurer | UTender of shares Common Stock | -30,386 | - | - | 125,675 | Oct 7, 2025 |
| Oct 7, 2025 | John H Tucker President and CEO | DDisposition to issuer Common Stock | -318,502 | - | - | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Jack A. Khattar director | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Klaus R Dr Veitinger director | DDisposition to issuer Stock Option (Right to Buy)derivative | -19,750 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | William Tober Abraham director | DDisposition to issuer Stock Option (Right to Buy)derivative | -19,750 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Mette Kirstine Agger director | DDisposition to issuer Stock Option (Right to Buy)derivative | -19,750 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Sara Bonstein director | DDisposition to issuer Stock Option (Right to Buy)derivative | -19,750 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Leonard D Schaeffer director | UTender of shares Common Stockindirect: Held by Schaeffer Holdings LLC | -43,104 | - | - | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Minnie Baylor-Henry director | DDisposition to issuer Stock Option (Right to Buy)derivative | -19,750 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Rachael Nokes CFO and Treasurer | DDisposition to issuer Common Stock | -125,675 | - | - | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Frederick M. Hudson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -19,750 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Minnie Baylor-Henry director | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,300 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Frederick M. Hudson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,300 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | John H Tucker President and CEO | DDisposition to issuer Stock Option (Right to Buy)derivative | -300,000 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Jack A. Khattar director | DDisposition to issuer Stock Option (Right to Buy)derivative | -19,750 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | William Tober Abraham director | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,300 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Rachael Nokes CFO and Treasurer | DDisposition to issuer Stock Option (Right to Buy)derivative | -132,670 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Klaus R Dr Veitinger director | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,300 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Sara Bonstein director | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,300 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Leonard D Schaeffer director | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Leonard D Schaeffer director | DDisposition to issuer Stock Option (Right to Buy)derivative | -19,750 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Frederick M. Hudson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -6,124 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | John H Tucker President and CEO | DDisposition to issuer Stock Option (Right to Buy)derivative | -84,500 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Minnie Baylor-Henry director | DDisposition to issuer Stock Option (Right to Buy)derivative | -6,124 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Jack A. Khattar director | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,300 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Klaus R Dr Veitinger director | DDisposition to issuer Stock Option (Right to Buy)derivative | -6,124 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Rachael Nokes CFO and Treasurer | DDisposition to issuer Stock Option (Right to Buy)derivative | -54,700 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Leonard D Schaeffer director | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,300 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | John H Tucker President and CEO | DDisposition to issuer Stock Option (Right to Buy)derivative | -249,000 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Minnie Baylor-Henry director | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,248 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Jack A. Khattar director | DDisposition to issuer Stock Option (Right to Buy)derivative | -6,124 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Rachael Nokes CFO and Treasurer | DDisposition to issuer Stock Option (Right to Buy)derivative | -6,426 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | John H Tucker President and CEO | DDisposition to issuer Stock Option (Right to Buy)derivative | -496,674 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | Rachael Nokes CFO and Treasurer | DDisposition to issuer Stock Option (Right to Buy)derivative | -13,850 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Jun 3, 2025 | William Tober Abraham director | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 5, 2025 |
| Jun 3, 2025 | Mette Kirstine Agger director | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 5, 2025 |
| Jun 3, 2025 | Minnie Baylor-Henry director | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 5, 2025 |
| Jun 3, 2025 | Sara Bonstein director | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 5, 2025 |
| Jun 3, 2025 | Frederick M. Hudson director | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 5, 2025 |
| Jun 3, 2025 | Jack A. Khattar director | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 5, 2025 |
| Jun 3, 2025 | Leonard D Schaeffer director | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 5, 2025 |
50 of 51 rows shown.
Insiders
Everyone who has filed a Form 4 here.
- William Tober Abrahamdirector
- Mette Kirstine Aggerdirector
- Minnie Baylor-Henrydirector
- Sara Bonsteincfo, officer, director
- Frederick M. Hudsondirector
- Jack A. Khattarceo, president, officer, director
- Rachael NokesCFO and Treasurer
- Leonard D Schaefferdirector
- John H TuckerPresident and CEO
- Klaus R Dr Veitingerdirector
Questions about SCPH
Answered from the filings on this page, as of the latest one.
Are insiders buying SCPH?
No. In the last 90 days no insider at scPharmaceuticals Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade SCPH on the open market?
No open-market trade has been scored at scPharmaceuticals Inc.. The latest Form 4 on file was filed on Oct 7, 2025 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at scPharmaceuticals Inc.?
10 people have filed a Form 4 at scPharmaceuticals Inc., among them William Tober Abraham (director), Mette Kirstine Agger (director), Minnie Baylor-Henry (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.